大肠埃希菌表达的恶性疟原虫裂殖子表面蛋白MSP1-42的免疫原性

来源 :中国血吸虫病防治杂志 | 被引量 : 0次 | 上传用户:andytong0123
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的纯化大肠埃希菌Rosetta gami(DE3)表达的可溶性裂殖子表面蛋白1C末端蛋白(MSP1-42,3D7株),检测其体外抑制恶性疟原虫生长的效果。方法利用大肠埃希菌Rosetta gami(DE3)为宿主菌诱导表达MSP1-42,用带组氨酸标签的镍柱纯化可溶性的MSP1-42。6只新西兰白兔随机分为免疫组和对照组,每组3只。用MSP1-42与弗氏佐剂乳化后,皮下注射,抗原免疫剂量每次为200μg/只,共免疫4次,每次间隔2周。佐剂对照组以PBS代替抗原同法免疫。免疫前及末次免疫2周后取血,用酶联免疫吸附试验和间接荧光抗体试验检测血清中特异性抗体及其与天然抗原的反应,用含10%和20%免疫血清的培养基体外培养恶性疟原虫(海南分离株,Fcc1/HN),检测免疫血清体外抑制恶性疟原虫生长的效果。结果经镍柱纯化后获得纯度为95%以上的MSP1-42蛋白;免疫组个体在第4次免疫后血清特异性抗体的滴度依次为1:640000、1:640000、1:160000,间接荧光抗体试验检测表明MSP1-42免疫兔血清与恶性疟原虫表面蛋白有阳性反应;免疫血清能抑制恶性疟原虫在体外生长,在10%浓度时,3只免疫兔血清的抑制率依次为(51.9±24.2)%、(29.4±8.6)%和(86.7±7.4)%,在20%浓度时,抑制率分别为(93.3±7.5)%、(65.3±10.6)%和(96.4±1.0)%。结论大肠埃希菌Rosettagami(DE3)表达的MSP1-42蛋白免疫血清能识别恶性疟原虫天然抗原,体外培养能抑制恶性疟原虫的生长。 Objective To purify soluble mesenchymal stem cell surface protein 1C (MSP1-42, 3D7) expressed by Escherichia coli Rosetta gami (DE3) and test its inhibitory effect on the growth of Plasmodium falciparum in vitro. Methods MSP1-42 was induced by Escherichia coli Rosetta gami (DE3) as a host strain, and purified soluble MSP1-42.6 New Zealand white rabbits with histidine-tagged nickel column were randomly divided into immunization group and control group, 3 per group MSP1-42 and Freund’s adjuvant emulsified, subcutaneous injection, the antigen immunization dose of 200μg / each, a total of four immunizations, each interval of two weeks. Adjuvant control group with PBS instead of antigen immunization. Blood samples were collected two weeks before and after the last immunization. Serum specific antibodies and their reaction with natural antigens were detected by enzyme-linked immunosorbent assay (ELISA) and indirect fluorescent antibody test, and cultured in vitro with 10% and 20% immune serum medium Plasmodium falciparum (Hainan isolate, Fcc1 / HN) was used to test the effect of immune serum on inhibiting the growth of Plasmodium falciparum in vitro. Results The purity of MSP1-42 was over 95% after purified by Ni-P column. The titer of serum-specific antibody in the immunized group was 1: 640000, 1: 640000, 1: Antibody test showed that MSP1-42 immunized rabbit serum reacted positively with Plasmodium falciparum surface protein. Immune serum could inhibit the growth of Plasmodium falciparum in vitro. At 10% concentration, the inhibitory rates of three immunized rabbits were (51.9 ± 24.2%, 29.4 ± 8.6% and 86.7 ± 7.4%, respectively. The inhibition rates were (93.3 ± 7.5)%, (65.3 ± 10.6)% and (96.4 ± 1.0)% at 20% concentration respectively. Conclusion MSP1-42 protein serum expressed by Escherichia coli Rosettagami (DE3) can recognize the natural antigen of Plasmodium falciparum and inhibit the growth of Plasmodium falciparum in vitro.
其他文献
运用期权理念构建国家基本医疗卫生服务管理模式,提出了政府通过买入基本医疗卫生服务这个买方期权,对冲其对城乡居民承担的卖出买方期权的风险,建立社会保障部门、社区医疗
目的 探讨社会支持对护士工作-家庭冲突与心理控制能力的影响.方法 按随机整群抽样的方法 对4家综合医院的临床一线护士126人进行调查,均为女性;以社会支持总分评分情况分组,
皮质脊髓束Waller变性是由于其上运动神经元或轴突损伤引起的远端轴突和髓鞘顺行性变性.卒中是引起皮质脊髓束Waller变性的最常见原因.皮质脊髓束Waller变性的常规MRI显示为
对淤浆法高密度聚乙烯(HDPE)装置不同批次过渡料进行了性能评价,并进行了加工应用试验,同时对比了市场产品牌号用途。结果表明:不同批次过渡料性能相近,熔体流动速率在1.4~1.6 g/
采用P507与Cyanex272协同萃取分离回收浸出液中的Ni2+,Co2+,考察了初始pH值、有机相复配比(P/C)和水油相比(A/O)的影响.结果表明,协萃优化条件为:有机相皂化率50%,皂化时间30
目的 探讨临床Ⅰ期子宫内膜癌行不同手术切除范围治疗的临床意义,及其预后影响因素.方法 收集135例临床Ⅰ期子宫内膜癌的临床病理资料,其中行全子宫切除+双附件切除57例(A组)
目的 观察FOLFOX方案治疗局部进展期或转移性胃癌的疗效及不良反应.方法 经组织学证实的局部进展期或转移性胃腺癌患者96例,其中手术切除后行辅助化疗者21例,无法手术切除、
目的 评价达托霉素、万古霉素、替考拉宁、替加环素、头孢吡普、利奈唑胺等抗菌药物对血培养分离革兰阳性球菌的体外抗菌活性.方法 用微最肉汤稀释法测定达托霉素对499株血培
目的 探讨小儿肝间叶性错构瘤的临床特征与诊治方法.方法 结合文献,回顾性分析1998年2月至2007年10月南京军区普通外科研究所收治的8例肝间叶性错构瘤患儿的临床表现、诊断、
总结了对15例地震伤员应用湿性愈合理论进行压疮护理的体会.患者因多器官损伤合并全身皮肤多处擦伤,长时间深埋压迫,表现为Ⅱ、Ⅲ、Ⅳ期压疮,部分伤口合并细菌感染.根据压疮